These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 21884608)
21. Chronic obstructive pulmonary disease in patients who have HIV infection. Crothers K Clin Chest Med; 2007 Sep; 28(3):575-87, vi. PubMed ID: 17720045 [TBL] [Abstract][Full Text] [Related]
22. Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers. Taylor GH; Williams AA; Garzino-Demo A Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26656889 [TBL] [Abstract][Full Text] [Related]
23. HIV infection and advanced age emerging epidemiological, clinical, and management issues. Manfredi R Ageing Res Rev; 2004 Jan; 3(1):31-54. PubMed ID: 15164725 [TBL] [Abstract][Full Text] [Related]
24. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Crothers K; Huang L; Goulet JL; Goetz MB; Brown ST; Rodriguez-Barradas MC; Oursler KK; Rimland D; Gibert CL; Butt AA; Justice AC Am J Respir Crit Care Med; 2011 Feb; 183(3):388-95. PubMed ID: 20851926 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology of chronic obstructive pulmonary disease in the global HIV-infected population: a systematic review and meta-analysis protocol. Bigna JJ; Kenne AM; Asangbeh SL Syst Rev; 2017 Mar; 6(1):68. PubMed ID: 28356123 [TBL] [Abstract][Full Text] [Related]
26. Infection as a comorbidity of COPD. Sethi S Eur Respir J; 2010 Jun; 35(6):1209-15. PubMed ID: 20513910 [TBL] [Abstract][Full Text] [Related]
27. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
28. [HIV infection and AIDS in advanced age. Epidemiological and clinical issues, and therapeutic and management problems]. Manfredi R; Calza L Infez Med; 2004 Sep; 12(3):152-73. PubMed ID: 15711129 [TBL] [Abstract][Full Text] [Related]
29. Characteristics and outcomes of HIV-1-infected patients with acute respiratory distress syndrome. Nirappil FJ; Maheshwari A; Andrews J; Martin GS; Esper AM; Cribbs SK J Crit Care; 2015 Feb; 30(1):60-4. PubMed ID: 25466320 [TBL] [Abstract][Full Text] [Related]
30. Pulmonary function in an international sample of HIV-positive, treatment-naïve adults with CD4 counts > 500 cells/μL: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. Kunisaki KM; Niewoehner DE; Collins G; Nixon DE; Tedaldi E; Akolo C; Kityo C; Klinker H; La Rosa A; Connett JE; HIV Med; 2015 Apr; 16 Suppl 1(0 0):119-28. PubMed ID: 25711330 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J; Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248 [TBL] [Abstract][Full Text] [Related]
33. Non-infectious Pulmonary Diseases and HIV. Triplette M; Crothers K; Attia EF Curr HIV/AIDS Rep; 2016 Jun; 13(3):140-8. PubMed ID: 27121734 [TBL] [Abstract][Full Text] [Related]
34. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy. Fitzpatrick ME; Kunisaki KM; Morris A AIDS; 2018 Jan; 32(3):277-292. PubMed ID: 29194119 [TBL] [Abstract][Full Text] [Related]
35. Cigarette smoking in the HIV-infected population. Rahmanian S; Wewers ME; Koletar S; Reynolds N; Ferketich A; Diaz P Proc Am Thorac Soc; 2011 Jun; 8(3):313-9. PubMed ID: 21653534 [TBL] [Abstract][Full Text] [Related]
36. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda. Rubaihayo J; Tumwesigye NM; Konde-Lule J; Wamani H; Nakku-Joloba E; Makumbi F BMC Res Notes; 2016 Dec; 9(1):501. PubMed ID: 27927247 [TBL] [Abstract][Full Text] [Related]
37. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications. Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219 [TBL] [Abstract][Full Text] [Related]
38. Maintaining lung health with longstanding HIV. Collini P; Morris A Curr Opin Infect Dis; 2016 Feb; 29(1):31-8. PubMed ID: 26555039 [TBL] [Abstract][Full Text] [Related]
39. High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers. Makinson A; Hayot M; Eymard-Duvernay S; Quesnoy M; Raffi F; Thirard L; Bonnet F; Tattevin P; Abgrall S; Quantin X; Léna H; Bommart S; Reynes J; Le Moing V; Eur Respir J; 2015 Mar; 45(3):828-31. PubMed ID: 25323226 [No Abstract] [Full Text] [Related]
40. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]